U.S. Liquid Biopsy Market to Attain Valuation of USD 12,004.9 Million By 2032: Astute Analytica [Yahoo! Finance]
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
diagnostics, with a strong focus on early detection, treatment monitoring, and personalized medicine. New Delhi, May 08, 2024 (GLOBE NEWSWIRE) -- The U.S. liquid biopsy market size was valued at US$ 3,786.2 million in 2023 and is projected to surpass a market valuation of US$ 12,004.9 million by 2032 at a CAGR of 13.68% during the forecast period 2024–2032. U.S. Liquid Biopsy Market Revenue (USD Million), By Technology By Technology Multi Gene Parallel Analysis (NGS) Single Gene Analysis (PCR Microarrays) U.S. Liquid Biopsy Market Revenue (USD Million), By Biomarker By Biomarker Circulating Nucleic Acids CTC Exosomes/Microvesicles Circulating Proteins Buy This Premium Research Report@ https://www.astuteanalytica.com/industry-report/united-states-liquid-biopsy-market?buy_now=true&license_type=single Cancer remains a formidable health challenge in the United States, with a projected rise in cases. Nearly 1.9 million new diagnoses and over 609,000 deaths from ca
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- Guardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease Week [Yahoo! Finance]Yahoo! Finance
- Guardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease WeekBusiness Wire
- Rafay Announces New Platform-as-a-Service Capabilities for GPU-based Workloads, Empowering Customers to Quickly Leverage the Power of AI [Yahoo! Finance]Yahoo! Finance
- Triomics Automates Oncology Workflows With GenAI Powered Platform, Raises $15M [Yahoo! Finance]Yahoo! Finance
GH
Earnings
- 5/9/24 - Beat
GH
Sec Filings
- 5/16/24 - Form 4
- 5/16/24 - Form 4
- 5/16/24 - Form 4
- GH's page on the SEC website